The Anterior Gradient-2 Pathway as a Model for Developing Peptide-Aptamer Anti-Cancer Drug Leads that Stimulate p53 Function

By Fourtouna Argyro   Murray Euan   Nicholson Judith   Maslon Magdalena M.   Pang Lisa Y.   Dryden David T.F.   Hupp Ted R.  

Current Opinion in Chemical Biology, Vol. 3, Iss. 2, 2009-05 ,pp. : 124-137

Elsevier

Access to resources Recommend Favorite

A Small Synthetic Peptide, which Inhibits the p53-hdm2 Interaction, Stimulates the p53 Pathway in Tumour Cell Lines

By Chène P.   Fuchs J.   Bohn J.   García-Echeverría C.   Furet P.   Fabbro D.  

Journal of Molecular Biology, Vol. 299, Iss. 1, 2000-05 ,pp. : 245-253

Academic Press

Access to resources Recommend Favorite

Deactivation of anti-cancer drug letrozole to a carbinol metabolite by polymorphic cytochrome P450 2A6 in human liver microsomes

By Murai K.   Yamazaki H.   Nakagawa K.   Kawai R.   Kamataki T.  

Xenobiotica, Vol. 39, Iss. 11, 2009-11 ,pp. : 795-802

Informa Healthcare

Access to resources Recommend Favorite

Down-regulation of MDM2 and activation of p53 in human cancer cells by antisense 9-aminoacridine–PNA (peptide nucleic acid) conjugates

By Shiraishi Takehiko   Nielsen Peter E.  

Nucleic Acids Research, Vol. 32, Iss. 16, 2004-01 ,pp. : 4893-4902

Oxford University Press

Access to resources Recommend Favorite

Like p53, the Proliferation-Associated Protein p120 Accumulates in Human Cancer Cells Following Exposure to Anticancer Drugs

By Blagosklonny M.V.   Iglesias A.   Zhan Z.   Fojo T.  

Biochemical and Biophysical Research Communications, Vol. 244, Iss. 2, 1998-03 ,pp. : 368-373

Elsevier

Access to resources Recommend Favorite